Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter
NCT ID: NCT06458101
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2024-07-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Efficacy of Flexible Ureteroscope and Percutaneous Nephroscopic Surgery in the Treatment of 2-4cm Kidney Stones
NCT06507176
ESWL Vs Flexible Uretroscopy in Management of Upper Ureteric Stones a Prospective Randomized Study
NCT06722703
Ureteroscopy Combined With Negative Pressure Sheath Treatment of Kidney Stones
NCT06938113
Flexible urétéroscopy Versus Extracorporeal Shockwave Lithotripsy in Renal Calculi
NCT01604304
ESWL vs URS in Management of Upper Third Ureteric Calculi
NCT03559738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Group 2: Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal renal function;
* Aged between 18 and 70 years old
* Complete the operation under general anesthesia
Exclusion Criteria
* Previous history of renal transplantation or urinary diversion;
* Congenital malformation of urinary system;
* Abnormal coagulation mechanism due to blood system diseases, liver diseases, etc.
* Severe heart or lung disease, Malignant tumor and immunodeficiency state
* Urethral stricture
* Neurogenic bladder
* Operation under epidural anesthesia or spinal anesthesia
* Large amount of bleeding during operation should be observed by indwelling catheter to observe urine color
* High risk factors such as large amount of pus fur should be observed during operation.
* Urethral injury during operation leads to false passage
* Operation time is more than 90 minutes. Higher risk of bleeding or infection
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yi Shao
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIT2024-050
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.